High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC

Por Enriqueta Felip, Ana Vivancos, Susana Cedres, Alex Martinez-Marti, Alejandro Navarro, Joan Frigola, Caterina Carbonell, Patricia Irazno, Nuria Pardo, Ana Callejo, Mireia Soleda, Jose Jimenez, Javier Hernandez-Losa, Ramon Amat
Publicado em 2022-04-01